Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Alcohol-associated Liver Disease
How do you approach a conversation with a patient with a markedly positive PETH (>200 ug/L) who is insistent that they do not consume any alcohol?
Do you perform any subsequent testing?
Related Questions
With the growth of non-alcoholic beverages (e.g., NA beer, liquor, etc), how do you approach a patient's consumption of these products in the setting of alcohol related liver disease?
How has the move away from a strict 6 month period of sobriety impacted your patient selection criteria for transplant of patients with alcohol associated liver disease?
What factors into your choice to use craving-related medications (e.g., baclofen, naltrexone, acamprosate, etc.) in the management of alcohol use disorder?
How do you incorporate addiction medicine and counseling into your treatment plan for patients with alcohol associated liver disease?
For how long would you treat a patient with latent TB before allowing them to proceed with a liver transplant?
How has the GALAD score affected your practice for HCC screening?
How does managing a patient with concomitant alcohol related liver disease impact your choice of therapies?
Who would be the right candidate in which TIPS placement would reduce portal hypertension to allow for a previously unattainable procedure?
How do you incorporate palliative care specialists into the care of patients with chronic liver disease, especially those who may not be transplant candidates?
How does the identification of a hepatic adenoma in a male patient affect your management and evaluation?